Extensive preparatory steps have already been undertaken under PREVENT CSA. In PREVENT PCP, the preparation stage, focused on translating the shared need into common specifications, elaborating the business-case for each involved buyer and validating the findings with the market through an open market consultation. In addition, the SOTA analysis was updated. The consortium also defined the common evaluation methodology for the PCP tender and for the expected outcomes of the PCP Phases. In this stage, strong involvement of the industry was also ensured through several Open Market Consultation activities.
The Report on the Open Market Consultation is available under this link.
Based on the activities performed in the pre-tendering phase the Call for Tenders was prepared, which was followed by the proposal submissions, evaluation of proposals and the selection of the bidders to be awarded the PCP framework agreement and the PCP phase 1 contract.
All relevant PCP documentation is available on the Download subpage.
The OMC document mentions that the aimed publication date is June 2022.
It has been presented and discussed during the OMC main event (3:32:35 – Click here to watch the video). The summary is available on the OMC document and on the PREVENT PCP website under this link.
Yes, through our website, together with the recording of the webinar.
On the EU Survey platform. A link is available in our website and has been sent by email to all the participants to the webinars. (deadline: February 3rd 2022).
The exhaustive list will be included in the tender documents (to be published in June 2022).
Yes. We are expecting as many answers as possible to fine-tune our tender.
Members may have a role to play for the tender documents preparation and the evaluation of project results – way to improve the solution and meet more potential end-users’ needs.
Deadline: 3rd February 2022.
Yes, ideally, but we know innovation may not go as quickly as we would like it to. TRL 8 is the objective at the end of Phase 3.
The Companies will. The public buyers will just ask a discount in case of a PPI, the ability to exploit the data gathered by the companies on the pilot sites for their own use and the ability (under agreement) to grant access to that data to third parties.
The PREVENT PCP Consortium will support companies while they develop the solution. This support includes issues such as this one: we may support the awarded companies to find a way to be fully insured and work for us with serenity.
Yes! We shall just pay attention to the presentation of the role of each party within the consortium to understand how it should function.
If you haven’t asked for it in the registration form you filled for this meeting, you may contact the consortium by email : firstname.lastname@example.org
Of course, in the tender documents.
That is an issue (regarding national legislation). The relevant partner of PREVENT PCP will ask for special authorisations, but this is not sure yet.
Mainly the face recognition (prohibited in many EU member states in public areas). Identification within PREVENT PCP should then be based on non-biometric elements such as clothes, attitude (skeletal silhouette). The tender documentation shall provide a full description of the expected technologies.
Yes, clearly: addressing our challenge is up to the competing companies. We may just evaluate the results and costs (evaluation process will be mentioned in the tender documents). Still, if any additional features may be added, they can only be evaluated under the criteria exposed in the tender documentation and the delivered results, in order to guarantee a fair procedure.
It hasn’t been decided yet: you will have to refer to the tender documentation.
Biometrics has been explored by the SOTA as a possible answer to PREVENT PCP challenges (as the technology exists). The national law in most member states doesn’t allow the exploitation of biometrics data. That is the reason why, currently, the Prevent PCP group encourages to explore other technical solutions, as solution using biometrics may possibly not be allowed to be tested during the pilot phase of our project.
Canada isn’t listed as an associated country for the Horizon 2020 programme. Still, a Canadian company can compete in our PCP if (as mentioned in the PIN) the performance of 100% of the R&D for PREVENT PCP in EU member states and/or the associated countries. Foreign companies with an establishment in one of those countries (EU27 + associated countries) may be accepted. Here is the list of associated countries: Albania, Bosnia, Faroe Islands, North Macedonia, Iceland, Israel, Moldavia, Montenegro, Norway, Serbia, Switzerland, Tunisia, Turkey and Ukraine.
The presentations are available on the project website by the end of each webinar and on the YouTube channel.
This would disclose personal data. Still, you can contact the PREVENT PCP Consortium (email@example.com) in order to be included in a mailing list where your contact details will be accessible to all the other recipients.
PCP instrument doesn't exist in the Italian public procurement legislation, but Italian public procurers can launch a PCP based on the EU Directive.
This is still under evaluation from a legal point of view. During phase 2, companies will be allowed to laboratory-test their prototypes in some operators’ premises.
Yes, all requirements will be specified in tender document.
It will be sent to those who registered during the week and will be annexed to the Report on the OMC (will be published on the project website).